TNF and Miyoshi myopathy: Zhao achieved PD-1-deficient CTLs based on CRISPR/Cas9 technology and found that the secretion of TNF-α and IFN-γ increased several times, promoted apoptosis of cocultured MM cells, inhibited tumor growth and prolonged survival within in vivo models of MM (54).